针对具有治疗潜力的转移的单碳代谢脆弱性
bioRxiv : the preprint server for biology
|February 23, 2026
概括
转移包括复杂的信号传输. 研究人员发现,单碳和SSP代谢途径抑制瘤转移,识别新的化合物以向这些途径用于癌症治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢途径 代谢途径
背景情况:
- 瘤进展与增加的细胞自主性和复杂的信号网络有关.
- 驱动癌症转移的特定信号通路在很大程度上仍未定义.
- 了解这些途径对于开发有效的抗转移疗法至关重要.
研究的目的:
- 确定关键的新陈代谢途径和参与抑制瘤转移的基因.
- 为了研究特定代谢途径在癌细胞远离地点的殖民化中的作用.
- 通过准这些代谢途径,发现能够阻断瘤转移的新型化合物.
主要方法:
- 利用转移性功能查来识别相关的代谢途径和基因.
- 具有不同转移潜力的工程癌细胞,以验证代谢途径功能.
- 测试已知的抑制剂和确定针对已知的基因和途径的新型化合物.
主要成果:
- 确定了单碳和SSP代谢途径作为瘤转移抑制的关键调节者.
- 证实了这些新陈代谢途径在控制不同组织的癌细胞殖民中的作用.
- 发现了三种新型化合物,可以抑制基因表达并阻断瘤转移.
结论:
- 瘤细胞重编程新陈代谢以增强转移,入侵和转移期间的生存.
- 已识别的代谢途径和基因为转移性疾病提供了有希望的治疗点.
- 这些新型化合物为指导转移性癌症的临床治疗提供了合理的策略.
更多相关视频
07:44Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
10.7K
07:03Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model
Published on: February 3, 2021
3.1K
相关概念视频
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
